In “Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population” by Spring et al. [J Infect Dis 2019:220 (1 December); DOI: 10.1093/infdis/jiz386] the panels in Figure 2 are mislabeled in the figure legend. The correct Figure 2 legend should read: Pharmacokinetic profiles in plasma (A and C) and urine (B and D, dotted lines) specimens from volunteers with the normal metabolizer (NM) phenotype (circles; n = 8), the intermediate metabolizer (IM) phenotype (triangles; n = 20), and the poor metabolizer (PM) phenotype (squares; n = 16) for primaquine (PQ; A and B) and carboxyprimaquine (cPQ; C and D) at scheduled time points after administration of 30 mg of PQ orally. Data are median values. The authors regret the error.
. 2019 Nov 27;221(7):1204. doi: 10.1093/infdis/jiz599
Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population
Michele D Spring
1,2, Jason C Sousa
5, Qigui Li
5, Christian A Darko
10, Meshell N Morrison
6, Sean R Marcsisin
12, Kristin T Mills
13, Brittney M Potter
5, Kristopher M Paolino
14, Patrick S Twomey
15, James E Moon
7, Donna M Tosh
16, Susan B Cicatelli
6, Jeffrey W Froude
17, Brandon S Pybus
5, Thomas G Oliver
3, William F Mccarthy
11, Norman C Waters
1, Philip L Smith
8, Gregory A Reichard
5, Jason W Bennett
4,9
Michele D Spring
1
Department of Bacterial and Parasitic Diseases, US Army Medical Directorate of the Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
2The Henry M. Jackson Foundation for the Advancement of Military Medicine
Find articles by Michele D Spring
Christian A Darko
10
General Dynamics Information Technology, Silver Spring
Find articles by Christian A Darko
Sean R Marcsisin
12
Food and Drug Administration, Boston, Massachusetts
Find articles by Sean R Marcsisin
Kristin T Mills
13
Davita Medical Group, Colorado Springs, Colorado
Find articles by Kristin T Mills
Kristopher M Paolino
14
Division of Infectious Disease, SUNY Upstate Medical University, Syracuse, New York
Find articles by Kristopher M Paolino
Patrick S Twomey
15
Licensing and Early Development–Oncology, Genentech, South San Francisco, California
Find articles by Patrick S Twomey
Donna M Tosh
16
Clinical Operations, Government and Public Health Solutions, ICON, Hinckley, Ohio
Find articles by Donna M Tosh
Jeffrey W Froude
17
Vaccines/Therapeutics Division, Defense Threat Reduction Agency, Fort Belvoir, Virginia
Find articles by Jeffrey W Froude
Thomas G Oliver
3Clinical Pharamacology Division, Uniformed Services University of the Health Sciences
Find articles by Thomas G Oliver
William F Mccarthy
11
U. S. Army Medical Materiel Development Activity, Fort Detrick, Maryland
Find articles by William F Mccarthy
Norman C Waters
1
Department of Bacterial and Parasitic Diseases, US Army Medical Directorate of the Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Find articles by Norman C Waters
Jason W Bennett
4Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences
9Bacterial Diseases Branch, Walter Reed Army Institute of Research
Find articles by Jason W Bennett
1
Department of Bacterial and Parasitic Diseases, US Army Medical Directorate of the Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
2The Henry M. Jackson Foundation for the Advancement of Military Medicine
3Clinical Pharamacology Division, Uniformed Services University of the Health Sciences
4Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences
5Experimental Therapeutics Branch
6Clinical Trials Center
7Malaria Vaccine Branch
8Center for Enabling Capabilities
9Bacterial Diseases Branch, Walter Reed Army Institute of Research
10
General Dynamics Information Technology, Silver Spring
11
U. S. Army Medical Materiel Development Activity, Fort Detrick, Maryland
12
Food and Drug Administration, Boston, Massachusetts
13
Davita Medical Group, Colorado Springs, Colorado
14
Division of Infectious Disease, SUNY Upstate Medical University, Syracuse, New York
15
Licensing and Early Development–Oncology, Genentech, South San Francisco, California
16
Clinical Operations, Government and Public Health Solutions, ICON, Hinckley, Ohio
17
Vaccines/Therapeutics Division, Defense Threat Reduction Agency, Fort Belvoir, Virginia
Issue date 2020 Apr 1.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
PMCID: PMC7075415 PMID: 31773155
This corrects the article "Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population" in volume 220 on page 1761.